相似文献
1
Treatment of Mycobacterium abscessus Infection.
Emerg Infect Dis. 2016 Mar;22(3):511-4. doi: 10.3201/eid2203.150828.
2
Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
PLoS One. 2015 Jan 12;10(1):e0116236. doi: 10.1371/journal.pone.0116236. eCollection 2015.
3
A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
Respir Med. 2014 Nov;108(11):1706-12. doi: 10.1016/j.rmed.2014.09.002. Epub 2014 Sep 16.
4
[Two cases of pulmonary infection by Mycobacterium abscessus in which drug susceptibility testing results conflicted with clinical courses].
Nihon Kokyuki Gakkai Zasshi. 2005 Apr;43(4):241-6.
5
Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy.
Radiology. 2012 Apr;263(1):260-70. doi: 10.1148/radiol.12111374. Epub 2012 Feb 27.
6
Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence.
Expert Rev Anti Infect Ther. 2013 Oct;11(10):1065-77. doi: 10.1586/14787210.2013.830413.
7
Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.
J Cyst Fibros. 2015 Jan;14(1):63-9. doi: 10.1016/j.jcf.2014.07.004. Epub 2014 Jul 30.
8
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
Am J Respir Crit Care Med. 2009 Nov 1;180(9):896-902. doi: 10.1164/rccm.200905-0704OC. Epub 2009 Aug 6.
9
CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
J Antimicrob Chemother. 2012 Jan;67(1):222-5. doi: 10.1093/jac/dkr420. Epub 2011 Oct 6.
10
Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus.
Intern Med. 2017;56(10):1253-1257. doi: 10.2169/internalmedicine.56.8053. Epub 2017 May 15.
引用本文的文献
1
In Vitro Susceptibility to Imipenem/Relebactam and Comparators in a Multicentre Collection of Complex Isolates.
Antibiotics (Basel). 2025 Jul 5;14(7):682. doi: 10.3390/antibiotics14070682.
2
Insights on the Pathogenesis of Infection in Patients with Cystic Fibrosis.
J Clin Med. 2025 May 16;14(10):3492. doi: 10.3390/jcm14103492.
3
Mycobacterium abscessus Hand Infection Mimicking Dactylitis Due to Spondyloarthritis: A Case Report.
Cureus. 2025 Mar 17;17(3):e80740. doi: 10.7759/cureus.80740. eCollection 2025 Mar.
4
Discovery of Biofilm-Inhibiting Compounds to Enhance Antibiotic Effectiveness Against Infections.
Pharmaceuticals (Basel). 2025 Feb 7;18(2):225. doi: 10.3390/ph18020225.
5
Use of epigenetically modified bacteriophage and dual beta-lactams to treat a Mycobacterium abscessus sternal wound infection.
Nat Commun. 2024 Nov 28;15(1):10360. doi: 10.1038/s41467-024-54666-4.
6
Multidrug-resistant infection in an anophthalmic socket treated with bedaquiline on a compassionate use basis: A case report.
Am J Ophthalmol Case Rep. 2024 Aug 8;36:102139. doi: 10.1016/j.ajoc.2024.102139. eCollection 2024 Dec.
7
Anterior and posterior surgical approach for vertebral lumbar osteomyelitis.
J Surg Case Rep. 2024 Aug 20;2024(8):rjae521. doi: 10.1093/jscr/rjae521. eCollection 2024 Aug.
8
Chemical optimization and derivatization of micrococcin p2 to target multiple bacterial infections: new antibiotics from thiopeptides.
World J Microbiol Biotechnol. 2024 Aug 20;40(10):307. doi: 10.1007/s11274-024-04109-5.
9
Risk Factors for and Outcomes Following Early Acquisition of Complex After Lung Transplantation.
Open Forum Infect Dis. 2024 Apr 12;11(5):ofae209. doi: 10.1093/ofid/ofae209. eCollection 2024 May.
10
The small non-coding RNA B11 regulates multiple facets of Mycobacterium abscessus virulence.
PLoS Pathog. 2023 Aug 21;19(8):e1011575. doi: 10.1371/journal.ppat.1011575. eCollection 2023 Aug.
本文引用的文献
1
Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.
Ann Am Thorac Soc. 2015 May;12(5):642-7. doi: 10.1513/AnnalsATS.201412-559OC.
2
The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea.
Diagn Microbiol Infect Dis. 2015 Feb;81(2):107-11. doi: 10.1016/j.diagmicrobio.2014.10.007. Epub 2014 Oct 25.
3
Soft Tissue Infection Caused by Rapid Growing Mycobacterium following Medical Procedures: Two Case Reports and Literature Review.
Ann Dermatol. 2014 Apr;26(2):236-40. doi: 10.5021/ad.2014.26.2.236. Epub 2014 Apr 30.
4
Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections.
J Antimicrob Chemother. 2014 Jul;69(7):1945-53. doi: 10.1093/jac/dku062. Epub 2014 Mar 14.
5
The Infectious Diseases Society of America emerging infections network: bridging the gap between clinical infectious diseases and public health.
Clin Infect Dis. 2014 Apr;58(7):991-6. doi: 10.1093/cid/cit932. Epub 2014 Jan 7.
6
Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs.
Respir Med. 2011 May;105(5):781-7. doi: 10.1016/j.rmed.2010.12.012. Epub 2011 Jan 5.
7
Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.
Am J Respir Crit Care Med. 2010 Oct 1;182(7):970-6. doi: 10.1164/rccm.201002-0310OC. Epub 2010 Jun 10.
8
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. doi: 10.1164/rccm.200604-571ST.
Zotero 插件